Generalizability of the EMBOLISE, MAGIC-MT, STEM, EMPROTECT, and MEMBRANE trials of middle meningeal artery embolization for chronic subdural hematoma: A single-center cohort analysis
Publication date: January 2027 Source: Clinical Neurology and Neurosurgery, Volume 272 Author(s): Naveen Arunachalam Sakthiyendran, Jimena Gonzalez-Salido, Alejandro Enriquez-Marulanda, Niels Pacheco-Barrios, Justin H. Granstein, Philipp Taussky, Christopher S. Ogilvy
Generalizability of the EMBOLISE, MAGIC-MT, STEM, EMPROTECT, and MEMBRANE trials of middle meningeal artery embolization for chronic subdural hematoma: A single-center cohort analysis. // Clinical Neurology and Neurosurgery. – URL: https://www.sciencedirect.com/science/article/pii/S030384672600363X?dgcid=rss_sd_all
Generalizability of the EMBOLISE, MAGIC-MT, STEM, EMPROTECT, and MEMBRANE trials of middle meningeal artery embolization for chronic subdural hematoma: A single-center cohort analysis. Clinical Neurology and Neurosurgery. https://www.sciencedirect.com/science/article/pii/S030384672600363X?dgcid=rss_sd_all
“Generalizability of the EMBOLISE, MAGIC-MT, STEM, EMPROTECT, and MEMBRANE trials of middle meningeal artery embolization for chronic subdural hematoma: A single-center cohort analysis.” Clinical Neurology and Neurosurgery.
@article{article41313,
title = {Generalizability of the EMBOLISE, MAGIC-MT, STEM, EMPROTECT, and MEMBRANE trials of middle meningeal artery embolization for chronic subdural hematoma: A single-center cohort analysis},
journal = {Clinical Neurology and Neurosurgery},
url = {https://www.sciencedirect.com/science/article/pii/S030384672600363X?dgcid=rss_sd_all}
}